Mechanisms of vessel regression: Toward an understanding of the resolution of angiogenesis

Current Topics in Microbiology and Immunology

Volumn 367, Issue , 2013, Pages 3-32

  Wietecha, Mateusz S ^a   Cerny, Wendy L ^a   Dipietro, Luisa A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; BINDING PROTEIN; CANSTATIN; ENDOSTATIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; METICRANE; OXYGEN; PEDF PROTEIN; REGULATOR PROTEIN; SPRY2 PROTEIN; TSP PROTEIN; TUMSTATIN; UNCLASSIFIED DRUG; VASOHIBIN; VASOSTATIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BIOMECHANICS; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELLS; ENDOTHELIUM CELL; EXPERIMENTAL ANIMAL; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HYPOXIA; MOLECULAR BIOLOGY; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; TISSUE PERFUSION; TISSUE REGENERATION; TISSUE REPAIR; VESSEL REGRESSION; WOUND HEALING;

ANIMALS; APOPTOSIS; BIOMECHANICS; BLOOD VESSELS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; WOUND HEALING;

ANIMALIA;

EID: 84876587380     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2012-287     Document Type: Article

References (102)

1. Ando J, Yamamoto K (2009) Vascular mechanobiology: endothelial cell responses to fluid shear stress. Circ J 73:1983-1992
2. Aurora AB, Biyashev D, Mirochnik Y, Zaichuk TA, Sanchez-Martinez C, Renault MA, Losordo D, Volpert OV (2010) NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement. Blood 116:475-484
3. Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, McDonald DM (2006) Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 290:H547-H559
4. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H (2009) The role of vascular endothelial growth factor in wound healing. J Surg Res 153:347-358
5. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601
6. Benjamin LE, Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGFB and VEGF. Development 125:1591-1598
7. Bhadada SV, Goyal BR, Patel MM (2011) Angiogenic targets for potential disorders. Fundam Clin Pharmacol 25:29-47
8. Bloor CM (2005) Angiogenesis during exercise and training. Angiogenesis 8:263-271
9. Bluff JE, O'Ceallaigh S, O'Kane S, Ferguson MW, Ireland G (2006) The microcirculation in acute murine cutaneous incisional wounds shows a spatial and temporal variation in the functionality of vessels. Wound Repair Regen 14:434-442
10. Bodnar RJ, Yates CC, Rodgers ME, Du X, Wells A (2009) IP-10 induces dissociation of newly formed blood vessels. J Cell Sci 122:2064-2077
11. Bornstein P (2009) Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 3:189-200
12. Bou-Gharios G, Ponticos M, Rajkumar V, Abraham D (2004) Extra-cellular matrix in vascular networks. Cell Prolif 37:207-220
13. Broadhead ML, Becerra SP, Choong PF, Dass CR (2010) The applied biochemistry of PEDF and implications for tissue homeostasis. Growth Factors 28:280-285
14. Cabrita MA, Christofori G (2008) Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 11:53-62
15. Cai J, Wu L, Qi X, Li Calzi S, Caballero S, Shaw L, Ruan Q, Grant MB, Boulton ME (2011) PEDF regulates vascular permeability by a gamma-secretase- mediated pathway. PLoS ONE 6:e21164
16. Califano JP, Reinhart-King CA (2010) Exogenous and endogenous force regulation of endothelial cell behavior. J Biomech 43:79-86
17. Cao Y, Xue L (2004) Angiostatin. Semin Thromb Hemost 30:83-93
18. Chappell JC, Wiley DM, Bautch VL (2012) How blood vessel networks are made and measured. Cell Tiss Org 195:94-107
19. Chen RR, Silva EA, Yuen WW, Mooney DJ (2007) Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24:258-264
20. Cheng C, Haasdijk R, Tempel D, van de Kamp EH, Herpers R, Bos F, Den Dekker WK, Blonden LA, de Jong R, Burgisser PE, Chrifi I, Biessen EA, Dimmeler S, Schulte-Merker S, Duckers HJ (2012) Endothelial cell-specific FGD5 involvement in vascular pruning defines neovessel fate in mice. Circulation 125:3142-3159
21. Cheresh DA, Stupack DG (2008) Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 27:6285-6298
22. Cuevas I, Boudreau N (2009) Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds. Adv Cancer Res 103:25-42
23. Davis GE, Saunders WB (2006) Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J Investig Dermatol Symp Proc 11:44-56
24. Davis GE, Senger DR (2005) Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97:1093-1107
25. Dejana E, Orsenigo F, Lampugnani MG (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115-2122
26. Dimmeler S, Zeiher AM (2000) Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87:434-439
27. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47:149-161
28. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659
29. Eble JA, Niland S (2009) The extracellular matrix of blood vessels. Curr Pharm Des 15:1385-1400
30. Egginton S, Gaffney E (2010) Tissue capillary supply-it's quality not quantity that counts! Exp Physiol 95:971-979
31. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA (1998) Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140:1255-1263
32. Eming SA, Krieg T (2006) Molecular mechanisms of VEGF-A action during tissue repair. J Investig Dermatol Symp Proc 11:79-86
33. Eming SA, Brachvogel B, Odorisio T, Koch M (2007) Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem 42:115-170
34. Folkman J (1974) Tumor angiogenesis. Adv Cancer Res 19:331-358
35. Fukumura D, Jain RK (2008) Imaging angiogenesis and the microenvironment. Apmis 116:695- 715
36. Geudens I, Gerhardt H (2011) Coordinating cell behaviour during blood vessel formation. Development 138:4569-4583
37. Ghajar CM, George SC, Putnam AJ (2008) Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr 18:251-278
38. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91:1071-1121
39. Gosain A, Matthies AM, Dovi JV, Barbul A, Gamelli RL, DiPietro LA (2006) Exogenous proangiogenic stimuli cannot prevent physiologic vessel regression. J Surg Res 135:218-225
40. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453:314-321
41. Hellberg C, Ostman A, Heldin CH (2010) PDGF and vessel maturation. Recent Results Cancer Res 180:103-114
42. Hickey MM, Simon MC (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 76:217-257
43. Ho TC, Chen SL, Yang YC, Liao CL, Cheng HC, Tsao YP (2007) PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc Res 76:213-223
44. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998
45. Hosomichi J, Yasui N, Koide T, Soma K, Morita I (2005) Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor. Biochem Biophys Res Commun 335:756-761
46. Hungerford JE, Little CD (1999) Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J Vasc Res 36:2-27
47. Hurley JR, Balaji S, Narmoneva DA (2010) Complex temporal regulation of capillary morphogenesis by fibroblasts. Am J Physiol Cell Physiol 299:C444-C453
48. Im E, Kazlauskas A (2006) New insights regarding vessel regression. Cell Cycle 5:2057-2059
49. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685-693
50. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58-62
51. Kniazeva E, Putnam AJ (2009) Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D. Am J Physiol Cell Physiol 297:C179-C187
52. Konson A, Pradeep S, D'Acunto CW, Seger R (2011) Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrest. J Biol Chem 286:3540-3551
53. Korff T, Kimmina S, Martiny-Baron G, Augustin HG (2001) Blood vessel maturation in a 3- dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. Faseb J 15:447-457
54. Korn C, Augustin HG (2012) Born to die: blood vessel regression research coming of age. Circulation 125:3063-3065
55. Kyriakides TR, Maclauchlan S (2009) The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal 3:215-225
56. Lange-Asschenfeldt B, Velasco P, Streit M, Hawighorst T, Pike SE, Tosato G, Detmar M (2001) The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses. J Invest Dermatol 117:1036-1041
57. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 197:1537-1549
58. Lawler PR, Lawler J (2012) Molecular basis for the regulation of angiogenesis by thrombospondin- 1 and -2. Cold Spring Harb Perspect Med 2:a006627
59. London NR, Whitehead KJ, Li DY (2009) Endogenous endothelial cell signaling systems maintain vascular stability. Angiogenesis 12:149-158
60. Maclauchlan S, Skokos EA, Agah A, Zeng J, Tian W, Davidson JM, Bornstein P, Kyriakides TR (2009) Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF. J Histochem Cytochem 57:301-313
61. Mirochnik Y, Kwiatek A, Volpert OV (2008) Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments. Curr Drug Targets 9:851-862
62. Modlich U, Kaup FJ, Augustin HG (1996) Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74:771-780
63. Mosher DF, Adams JC (2012) Adhesion-modulating/matricellular ECM protein families: a structural, functional and evolutionary appraisal. Matrix Biol 31:155-161
64. Mundel TM, Kalluri R (2007) Type IV collagen-derived angiogenesis inhibitors. Microvasc Res 74:85-89
65. Murakami M (2012) Signaling required for blood vessel maintenance: molecular basis and pathological manifestations. Int J Vasc Med 2012:293641
66. Murakami M, Simons M (2009) Regulation of vascular integrity. J Mol Med (Berl) 87:571-582
67. Naldini A, Pucci A, Bernini C, Carraro F (2003) Regulation of angiogenesis by Th1- and Th2- type cytokines. Curr Pharm Des 9:511-519
68. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:1445-1452
69. Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Cancer Res 65:3967- 3979
70. Occleston NL, Metcalfe AD, Boanas A, Burgoyne NJ, Nield K, O'Kane S, Ferguson MW (2010) Therapeutic improvement of scarring: mechanisms of scarless and scar-forming healing and approaches to the discovery of new treatments. Dermatol Res Pract
71. Olfert IM, Birot O (2011) Importance of anti-angiogenic factors in the regulation of skeletal muscle angiogenesis. Microcirculation 18:316-330
72. Owen MR, Alarcon T, Maini PK, Byrne HM (2009) Angiogenesis and vascular remodelling in normal and cancerous tissues. J Math Biol 58:689-721
73. Phelps EA, Garcia AJ (2010) Engineering more than a cell: vascularization strategies in tissue engineering. Curr Opin Biotechnol 21:704-709
74. Pollina EA, Legesse-Miller A, Haley EM, Goodpaster T, Randolph-Habecker J, Coller HA (2008) Regulating the angiogenic balance in tissues: a potential role for the proliferative state of fibroblasts. Cell Cycle 7:2056-2070
75. Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146:873-887
76. Ribatti D, Nico B, Crivellato E (2009) Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis 12:101-111
77. Rodriguez PG, Felix FN, Woodley DT, Shim EK (2008) The role of oxygen in wound healing: a review of the literature. Dermatol Surg 34:1159-1169
78. Rogers PA (1996) Structure and function of endometrial blood vessels. Hum Reprod Update 2:57-62
79. Sakamaki K (2004) Regulation of endothelial cell death and its role in angiogenesis and vascular regression. Curr Neurovasc Res 1:305-315
80. Sato Y (2011) Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy. Cancer Sci 102:1253-1256
81. Sato Y, Sonoda H (2007) The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler Thromb Vasc Biol 27:37-41
82. Schafer M, Werner S (2008) Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 9:628-638
83. Schramm JC, Dinh T, Veves A (2006) Microvascular changes in the diabetic foot. Int J Low Extrem Wounds 5:149-159
84. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM (2010) Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 19:134-148
85. Semenza GL (2010) Vascular responses to hypoxia and ischemia. Arterioscler Thromb Vasc Biol 30:648-652
86. Seppinen L, Sormunen R, Soini Y, Elamaa H, Heljasvaara R, Pihlajaniemi T (2008) Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biol 27:535-546
87. Shaterian A, Borboa A, Sawada R, Costantini T, Potenza B, Coimbra R, Baird A, Eliceiri BP (2009) Real-time analysis of the kinetics of angiogenesis and vascular permeability in an animal model of wound healing. Burns 35:811-817
88. Shaw TJ, Martin P (2009) Wound repair at a glance. J Cell Sci 122:3209-3213
89. Sorrell JM, Baber MA, Caplan AI (2008) Human dermal fibroblast subpopulations; differential interactions with vascular endothelial cells in coculture: nonsoluble factors in the extracellular matrix influence interactions. Wound Repair Regen 16:300-309
90. Staton CA, Reed MW, Brown NJ (2009) A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 90:195-221
91. Stoneman VE, Bennett MR (2009) Role of Fas/Fas-L in vascular cell apoptosis. J Cardiovasc Pharmacol 53:100-108
92. Swift ME, Kleinman HK, DiPietro LA (1999) Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 79:1479-1487
93. Szpaderska AM, Walsh CG, Steinberg MJ, DiPietro LA (2005) Distinct patterns of angiogenesis in oral and skin wounds. J Dent Res 84:309-314
94. Thomas M, Augustin HG (2009) The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 12:125-137
95. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8:349-357
96. von Tell D, Armulik A, Betsholtz C (2006) Pericytes and vascular stability. Exp Cell Res 312:623-629
97. Wacker A, Gerhardt H (2011) Endothelial development taking shape. Curr Opin Cell Biol 23:676-685
98. Wietecha MS, Chen L, Ranzer MJ, Anderson K, Ying C, Patel TB, DiPietro LA (2012) Sprouty2 downregulates angiogenesis during mouse skin wound healing. Am J Physiol Heart Circ Physiol 300:H459-H467
99. Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Dipietro LA (2008) Regulation of scar formation by vascular endothelial growth factor. Lab Invest 88:579-590
100. Wong VW, Sorkin M, Glotzbach JP, Longaker MT, Gurtner GC (2011) Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol 2011:969618
101. Yates CC, Whaley D, Kulasekeran P, Hancock WW, Lu B, Bodnar R, Newsome J, Hebda PA, Wells A (2007) Delayed and deficient dermal maturation in mice lacking the CXCR3 ELRnegative CXC chemokine receptor. Am J Pathol 171:484-495
102. Yuen WW, Du NR, Chan CH, Silva EA, Mooney DJ (2010) Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc Natl Acad Sci USA 107:17933-17938